Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Net other income and expenses outside core operations
Percentile
P50
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.08M | -6.4% |
| 2024 | $8.64M | -78.0% |
| 2023 | $39.25M | +2660.1% |
| 2022 | $-1.53M | -333.1% |
| 2021 | $-354000.00 | - |